AndresChangMDPhD

Hematologic Oncology

Instructor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University

Dr. Chang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Andres Chang is a hematologist in Atlanta, GA and is affiliated with Emory University Hospital Midtown, and Emory University Hospital. He received his medical degree from University of Kentucky College of Medicine. He also speaks multiple languages, including Spanish. He specializes in hematologic oncology.

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2020
Emory University School of MedicineResidency, Internal Medicine, 2014 - 2016
University of Kentucky College of MedicineClass of 2014, MD PhD, High Honors

PubMed

Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without Transfusion.
Ellen Marin, Aseala Abousaud, Kathleen Davis, Bradley Sumrall, Shiyong Li
Ejhaem. 2025-02-01
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapy.
Rahul K Nayak, Meili Aiello, Laneisha Marielis Maldonado, Tarralyn Y Clark, Zachary S Buchwald
Journal for Immunotherapy of Cancer. 2024-10-26
1 citations
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer.
Rajesh M Valanparambil, Lilin Lai, Margaret A Johns, Meredith Davis-Gardner, Susanne L Linderman
NPJ Vaccines. 2023-11-21

Andres Chang, MD, PhD, and Rafi Ahmed, PhD, on Immune Responses After COVID Vaccination in NHL/CLL PatientsOctober 26th, 2022
Influenza Vaccination Status in DLBCL Poorly DocumentedJuly 5th, 2019